Senetek and ICN partner for anaphylactic injector:
This article was originally published in Clinica
Executive Summary
Senetek of Napa, California and ICN Pharmaceuticals of New York, have signed an agreement that gives ICN worldwide rights to AdrenaJect, Senetek's epinephrine filled ReliaJect autoinjector. The device is used by those suffering anaphylactic shock, caused by such events as adverse allergy reactions from insect bites or foods. Senetek will also make available the autoinjector for other therapeutics such as pains management and infertility.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.